46 results
Page 2 of 3
8-K
EX-99.1
5xjpknpptg5ls9v9m
4 Apr 22
Petros Pharmaceuticals Reports Year End 2021 Financial Results and Corporate Highlights
4:15pm
424B3
giuj9gca
14 Jan 22
Prospectus supplement
5:18pm
424B5
x6lf 6q82tmx
23 Dec 21
Prospectus supplement for primary offering
5:01pm
424B5
mpf m75zpwpl7zot
1 Dec 21
Prospectus supplement for primary offering
5:10pm
DEF 14A
7m0swk oidj6z
22 Nov 21
Definitive proxy
4:37pm
424B5
4syry0yaj
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-Q
okwtthshz30s0x3r
14 May 21
Quarterly report
4:31pm
10-K
qu8yv7 16bb
31 Mar 21
Annual report
4:30pm
10-K
EX-10.2
ao0gk0 tyx
31 Mar 21
Annual report
4:30pm
S-3
tv9hhj4d
29 Jan 21
Shelf registration
4:48pm
8-K/A
EX-99.1
40f6te6p84t72vs7jt
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K/A
EX-99.2
5xz9 m47q1tq
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
EX-99.1
k1sy2p7z44q qiv6
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
424B3
h6ys06qvdsq
2 Nov 20
Prospectus supplement
12:00am